{"transactions":[{"id":767812,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-05-21T21:00:24.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":12000,"derivative":{"exercise_price":42.26,"exercise_date":"2027-05-19","expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001344381-26-000004","document":"form4-05212026_050518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000134438126000004/form4-05212026_050518.xml","form_type":"4"}},{"id":767811,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T21:00:24.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":29750,"source":{"system":"sec-edgar","filing":"0001344381-26-000004","document":"form4-05212026_050518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000134438126000004/form4-05212026_050518.xml","form_type":"4"}},{"id":798720,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-29T00:35:09.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $17,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":5475,"source":{"system":"sec-edgar","filing":"0001344381-26-000002","document":"form4-04282026_080405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000134438126000002/form4-04282026_080405.xml","form_type":"4"}},{"id":921314,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T01:35:17.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $17,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":5389,"source":{"system":"sec-edgar","filing":"0001344381-26-000001","document":"form4-02032026_080213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000134438126000001/form4-02032026_080213.xml","form_type":"4"}},{"id":1007918,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T02:05:15.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $17,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":5316,"source":{"system":"sec-edgar","filing":"0001344381-25-000005","document":"form4-11042025_091112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000134438125000005/form4-11042025_091112.xml","form_type":"4"}},{"id":1079671,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-30T01:05:16.000Z","date":"2025-07-25","kind":"grant","planned":false,"acquired":true,"shares":112,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person in lieu of quarterly retainer fees of $17,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":5219,"source":{"system":"sec-edgar","filing":"0001415889-25-020519","document":"form4-07292025_090712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000141588925020519/form4-07292025_090712.xml","form_type":"4"}},{"id":1097640,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T01:15:18.000Z","date":"2025-06-27","kind":"grant","planned":false,"acquired":true,"shares":2143,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 12, 2026. The RSUs will become fully vested in the event that the Issuer is subject to a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":5107,"source":{"system":"sec-edgar","filing":"0001415889-25-018840","document":"form4-07012025_090714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000141588925018840/form4-07012025_090714.xml","form_type":"4"}},{"id":1145198,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-05-16T23:00:22.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":21.15,"exercise_date":"2026-05-15","expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-25-013504","document":"form4-05162025_070518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925013504/form4-05162025_070518.xml","form_type":"4"}},{"id":1145197,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T23:00:22.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":25750,"source":{"system":"sec-edgar","filing":"0001415889-25-013504","document":"form4-05162025_070518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925013504/form4-05162025_070518.xml","form_type":"4"}},{"id":1462308,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T01:05:16.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":2964,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 12, 2025. The RSUs will become fully vested in the event that the Issuer is subject to a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":2964,"source":{"system":"sec-edgar","filing":"0001415889-24-019069","document":"form4-07022024_090713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000141588924019069/form4-07022024_090713.xml","form_type":"4"}},{"id":1520566,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-05-10T20:06:03.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":6.82,"exercise_date":"2025-05-08","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-24-012852","document":"form4-05102024_040555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924012852/form4-05102024_040555.xml","form_type":"4"}},{"id":1520565,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T20:06:03.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19250,"source":{"system":"sec-edgar","filing":"0001415889-24-012852","document":"form4-05102024_040555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924012852/form4-05102024_040555.xml","form_type":"4"}},{"id":1753068,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-01T01:35:10.000Z","date":"2023-10-27","kind":"grant","planned":false,"acquired":true,"shares":515,"price":25.03,"value":12890.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was issued to the Reporting Person in lieu of quarterly retainer fees of $14,375 for service on the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares are fully vested and may be exercised at any time."}],"balance_after":515,"derivative":{"exercise_price":38.26,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":515},"source":{"system":"sec-edgar","filing":"0001415889-23-014639","document":"form4-10312023_091003.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000141588923014639/form4-10312023_091003.xml","form_type":"4"}},{"id":1819014,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-02T01:05:18.000Z","date":"2023-07-28","kind":"grant","planned":false,"acquired":true,"shares":428,"price":29.68,"value":12703.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was issued to the Reporting Person in lieu of pro-rated quarterly retainer fees of $13,427.20 for service on the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares are fully vested and may be exercised at any time."}],"balance_after":428,"derivative":{"exercise_price":45.88,"expiration_date":"2033-07-27","underlying":"Common Stock","underlying_shares":428},"source":{"system":"sec-edgar","filing":"0001415889-23-011689","document":"form4-08012023_090811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000141588923011689/form4-08012023_090811.xml","form_type":"4"}},{"id":1884446,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-19T20:05:53.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":13500,"derivative":{"exercise_price":17.11,"exercise_date":"2024-05-17","expiration_date":"2033-05-16","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001209191-23-030963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919123030963/doc4.xml","form_type":"4"}},{"id":1884445,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:05:53.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":12750,"source":{"system":"sec-edgar","filing":"0001209191-23-030963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919123030963/doc4.xml","form_type":"4"}},{"id":1917942,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-19T00:10:35.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":120,"price":32.88,"value":3945.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was issued to the Reporting Person in lieu of pro-rated quarterly retainer fees of $4,230 for service on the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares are fully vested and may be exercised at any time."}],"balance_after":120,"derivative":{"exercise_price":51.4,"expiration_date":"2033-04-13","underlying":"Common Stock","underlying_shares":120},"source":{"system":"sec-edgar","filing":"0001415889-23-006661","document":"form4-04182023_080423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000141588923006661/form4-04182023_080423.xml","form_type":"4"}},{"id":1936607,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-29T01:45:11.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":10767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest in three (3) equal annual installments beginning on March 2, 2024. The option shares will become fully vested and exercisable in the event that the Issuer is subject to a change in control."}],"balance_after":10767,"derivative":{"exercise_price":56.65,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":10767},"source":{"system":"sec-edgar","filing":"0001415889-23-005536","document":"form4-03282023_090302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1344381/000141588923005536/form4-03282023_090302.xml","form_type":"4"}},{"id":2273421,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-13T00:42:51.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":9000,"derivative":{"exercise_price":21.38,"exercise_date":"2023-05-11","expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-22-028704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919122028704/doc4.xml","form_type":"4"}},{"id":2273420,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Williams Brinkley Ruth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T00:42:51.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":8250,"source":{"system":"sec-edgar","filing":"0001209191-22-028704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919122028704/doc4.xml","form_type":"4"}},{"id":2567643,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Brinkley Ruth Williams","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-16T22:16:01.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 24 equal monthly installments thereafter."}],"balance_after":15750,"derivative":{"exercise_price":23.61,"expiration_date":"2031-09-13","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-21-056459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919121056459/doc4.xml","form_type":"4"}},{"id":2567642,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":45206,"kind":"person","name":"Williams Brinkley Ruth","position":1,"cik":"0001344381","reported_name":"Brinkley Ruth Williams","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-16T22:16:01.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001209191-21-056459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919121056459/doc4.xml","form_type":"4"}}]}